Skip to content

Research on the Application of Hybrid ESD in Early Esophageal Cancer

Research on the Application of Hybrid ESD in Early Esophageal Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103509
Enrollment
Unknown
Registered
2025-05-30
Start date
2025-06-15
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early esophageal cancer

Interventions

H-ESD group:Surgical treatment was performed using the Hybrid ESD method
C-ESD group:Surgical treatment was performed using the traditional ESD method

Sponsors

Xuancheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The clinical data are complete and valid; 2. Confirmed by endoscopic examination and pathology, the esophageal tumor lesions of the patients were all confined to the mucosal layer, meeting the clinical diagnostic criteria. The lesions were smaller than 3cm, presenting symptoms such as varying degrees of swallowing discomfort, dull pain behind the sternum, and foreign body sensation in the pharynx. Some patients were healthy during physical examination and had no clinical symptoms in daily life. 3. Meet the indications for ESD surgery; 4. Be informed of and consent to this research.

Exclusion criteria

Exclusion criteria: 1. The tumor lesion exceeds the esophageal mucosal layer, or local and distant metastasis occurs; 2.Accompanied by severe diseases of important organs such as the heart, lungs, brain, liver and kidneys; 3.Combined with blood and metabolic diseases; 4. Concurrent mental illness.

Design outcomes

Primary

MeasureTime frame
Operation time;

Secondary

MeasureTime frame
The overall resection rate and R0 resection rate;Surgical complications such as bleeding and perforation;

Countries

China

Contacts

Public ContactHui Qu

Xuancheng People's Hospital

15850070716@163.com+86 133 4563 2728

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026